Better Buy: Inovio Pharmaceuticals vs. Novavax
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to dominate this market were much less successful. Tha...